We are live on ! Find out more
Vanguard Global Advisers

Vanguard Global Advisers Portfolio holdings

AUM $215B
This Fund
S&P 500
This Quarter Est. Return
-1.44%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$187B
AUM Growth
–
Cap. Flow
+$194B
Cap. Flow %
104.07%
Top 10 Hldgs %
40.78%
Holding
3,683
New
3,683
Increased
–
Reduced
–
Closed
–

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Miscellaneous 24.45%
2 Technology 22.86%
3 Financials 11.48%
4 Communication Services 7.14%
5 Consumer Discretionary 7.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TKC icon
2726
Turkcell
TKC
$4.38B
$100K ﹤0.01%
+16,617
New +$106K
ZURA icon
2727
Zura Bio
ZURA
$403M
$100K ﹤0.01%
+16,821
New +$102K
BOTJ icon
2728
Bank Of The James
BOTJ
$124M
$99.5K ﹤0.01%
+4,831
New +$95.7K
PERI icon
2729
Perion Network
PERI
$341M
$99.5K ﹤0.01%
+9,737
New +$88.2K
SVIA
2730
Silvia, Inc. Common Stock
SVIA
$348M
$99.4K ﹤0.01%
+47,102
New +$131K
KEP icon
2731
Korea Electric Power
KEP
$14B
$99.4K ﹤0.01%
+6,972
New +$132K
ANGX
2732
Angel Studios
ANGX
$824M
$99.3K ﹤0.01%
+32,541
New +$125K
OLPX
2733
DELISTED
Olaplex Holdings
OLPX
$99.1K ﹤0.01%
+48,820
New +$74.9K
EVEX icon
2734
Eve Holding
EVEX
$655M
$99.1K ﹤0.01%
+39,954
New +$136K
RLGT icon
2735
Radiant Logistics
RLGT
$414M
$99.1K ﹤0.01%
+14,054
New +$98.6K
NAGE
2736
Niagen Bioscience
NAGE
$218M
$99.1K ﹤0.01%
+22,465
New +$121K
DCTH icon
2737
Delcath Systems
DCTH
$541M
$98.7K ﹤0.01%
+10,633
New +$103K
SPOK icon
2738
Spok Holdings
SPOK
$221M
$98K ﹤0.01%
+8,987
New +$114K
NGNE icon
2739
Neurogene
NGNE
$544M
$97.9K ﹤0.01%
+4,854
New +$94K
ASPN icon
2740
Aspen Aerogels
ASPN
$461M
$97.7K ﹤0.01%
+28,581
New +$96.3K
CHRS icon
2741
Coherus Oncology
CHRS
$185M
$97.7K ﹤0.01%
+57,809
New +$103K
RC
2742
Ready Capital
RC
$187M
$97.7K ﹤0.01%
+60,296
New +$115K
RMR icon
2743
The RMR Group
RMR
$307M
$97.6K ﹤0.01%
+6,306
New +$102K
ABEV icon
2744
Ambev
ABEV
$44.7B
$96.8K ﹤0.01%
+33,166
New +$94.8K
DNA icon
2745
Ginkgo Bioworks
DNA
$855M
$96.4K ﹤0.01%
+15,732
New +$131K
CABA icon
2746
Cabaletta Bio
CABA
$319M
$96.2K ﹤0.01%
+35,751
New +$99.3K
NECB icon
2747
Northeast Community Bancorp
NECB
$358M
$95.7K ﹤0.01%
+4,021
New +$94.9K
INFY icon
2748
Infosys
INFY
$46.1B
$95.5K ﹤0.01%
+7,068
New +$111K
LNKB
2749
DELISTED
LINKBANCORP
LNKB
$95.4K ﹤0.01%
+11,438
New +$99.1K
FSTR icon
2750
Foster
FSTR
$379M
$94.6K ﹤0.01%
+3,392
New +$100K

Similar funds

Vanguard Global Advisers's Q1 2026 Portfolio in Review

Q1 2026 is the first quarter with a 13F filing on record for Vanguard Global Advisers, which disclosed 3,683 positions worth $187B. Its ten largest holdings account for 41% of the portfolio.

Its largest position is Vanguard S&P 500 ETF: 39,600,312 shares worth $23.7B.

By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, followed by Technology and Financials.

  • Vanguard Global Advisers's largest Q1 2026 buy was Vanguard S&P 500 ETF: 39,600,312 shares worth $23.7B.
  • Vanguard Global Advisers's ten largest holdings make up 41% of its $187B portfolio in Q1 2026.
  • Vanguard Global Advisers disclosed 3,683 positions in Q1 2026, its first 13F filing on record.

Based on Vanguard Global Advisers's 13F filing for Q1 2026, filed 8 May 2026.